There's Optimism Over Moderna Report That Vaccine Is Nearly 95% Effective

Download Audio

The news from Cambridge-based Moderna is impressive. The biotech company reported Monday that the coronavirus vaccine it's developed has been found to be nearly 95% effective in late-stage clinical trials.

According to the nation's top infectious disease doctor, Anthony Fauci, the finding is "as good as it gets."

Moderna plans to apply for emergency-use authorization from the Food and Drug Administration, as does Pfizer, which reported last week that its vaccine has been more than 90% effective in preventing coronavirus infection in study participants.

Dr. Rick Malley is senior physician in Boston Children’s Hospital’s Division of Infectious Diseases. His research focuses on vaccine development.

Malley spoke with WBUR's All Things Considered host Lisa Mullins about his optimism surrounding the vaccines that are showing success, while stressing that the data are preliminary and will have to undergo intensive review.

This segment aired on November 16, 2020.


Headshot of Lisa Mullins

Lisa Mullins Host, All Things Considered
Lisa Mullins is the voice of WBUR’s All Things Considered. She anchors the program, conducts interviews and reports from the field.


Headshot of Lynn Jolicoeur

Lynn Jolicoeur Producer/Reporter
Lynn Jolicoeur is the field producer for WBUR's All Things Considered. She also reports for the station's various local news broadcasts.



More from WBUR

Listen Live